Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Obesity, Morbid: early-phase trial registry
8 of 20 indexed Obesity, Morbid trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #848 of 28,707 conditions by registered trial count.
20 US clinical trials · 8 currently recruiting · #848 of 28,707 conditions by registered trial count
Obesity, Morbid: 20 US clinical trials tracked, 8 recruiting.
Obesity, Morbid is the subject of 20 registered US clinical trials on ClinicalTrials.gov, 8 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 3 in Phase 1-2 (earlier-stage). The most active sponsor is Christopher C. Thompson, MD, MSc, running 2 of these trials.
Enrollment posture brief
Registry condition obesity-morbid
OPEN 8 | RECR 40% | LATE 1 | EARLY 3 | RANK #848 | SPON 2
Volume-matched condition peers
Nearest open-share peer: Achondroplasia (40% recruiting · 10 trials)
Obesity, Morbid lists 8 open slots (40% of 20 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Obesity, Morbid on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Obesity, Morbid recruits in line with its size-band peers.
8 of 20 indexed trials (40%) are open to enrollment, against a 39.7% average across 762 conditions with 20-99 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
Sponsorship of Obesity, Morbid trials is spread across many organizations.
Christopher C. Thompson, MD, MSc accounts for 2 of 20 trials (10%). 18 distinct sponsors appear on at least one study for this condition label.
-
Most Obesity, Morbid trials plan to enrol fewer than 100 people.
Median target enrolment is 36 among the 20 trials that report a genuine target (sentinel values excluded). 16 of those (80%) plan for fewer than 100 participants.
-
Obesity, Morbid research is mostly interventional.
15 interventional and 5 observational studies make up this index (75% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
20 total, page 1 of 1
Postextubation Use of Noninvasive Respiratory Support in Severely Obese Patients
Rush University Medical Center
NCT05918575
Trans-nasal Endoscopy for Bariatric Patients
Christopher C. Thompson, MD, MSc
NCT06200961
Investigating the Link Between Type 2 Immunity and NAFLD in Human Obesity
Mayo Clinic
NCT04232566
Time-restricted Eating Among Pregnant Females With Severe Obesity
University of Illinois at Chicago
NCT06477120
Study of Liraglutide (A Weight Loss Drug) in High Risk Obese Participants With Cognitive and Memory Issues
University of Chicago
NCT06171152
Efficacy and Safety of Endoscopic Antral Myotomy as a Novel Weight Loss Procedure
Christopher C. Thompson, MD, MSc
NCT05711758
Long-term, Substantial Weight Loss and Insulin Regulation of Lipolysis
Mayo Clinic
NCT03868592
Brown Adipose Tissue Activation by Spinal Cord Stimulation
Oregon Health and Science University
NCT04326192
Rural Engagement in TelemedTeam for Options in Obesity Treatment Solutions
University of Kansas Medical Center
NCT05710510
Biological Sample Repository for Gastrointestinal Disorders
Pichamol Jirapinyo, MD, MPH
NCT05874726
Positive Psychology Intervention for Patients Post-bariatric Surgery and Their Partners
Larissa McGarrity, Ph.D.
NCT05958615
Multimodal Analgesia Effect on Post Surgical Patient
University of California, Davis
NCT04240626
Clinical Investigation of the da Vinci Surgical System
Intuitive Surgical
NCT05682742
Evaluation of Bariatric Endoscopic Antral Myotomy (BEAM) as a Treatment for Obesity
Brigham and Women's Hospital
NCT05713071
Responsive Neurostimulation For Loss Of Control Eating
University of Pennsylvania
NCT03868670
Bariatric Surgery on Short Term Weight Loss- Related Changes in Gait
University of Florida
NCT01447316
Topiramate in Adolescents With Severe Obesity
University of Minnesota
NCT01859013
Contributing Factors in the Pathobiology of Airway Remodeling in Obesity
Duke University
NCT03115632
PET Imaging and Bariatric Surgery
Vanderbilt University Medical Center
NCT00801827
Efficacy of Vitamin D Supplementation in Obese Children
Columbia University
NCT02956408
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 2 |
| Phase 2 | 1 |
| Phase 4 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Obesity, Morbid records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Obesity, Morbid trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Obesity, Morbid page
20 registered trials, 8 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 8 Obesity, Morbid trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Christopher C. Thompson, MD, MSc sponsors the most Obesity, Morbid trials on record, review their full trial history before evaluating a specific study. See Christopher C. Thompson, MD, MSc's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Obesity, Morbid condition card totals 20 registered trials; most-linked intervention F-18 (fallypride); top US site state Massachusetts. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.